@

scioPhospho: protein profiling and phosphorylation status

Our scioPhospho analysis combines protein expression profiling using scioDiscover with analysis of the corresponding protein's phosphorylation status. More than 1,400 proteins are analyzed in parallel, covering key pathways in diseases such as cancer, neurological disorders and organ failure.  This combination provides a comprehensive overview of signaling events and pathway activity regulation in your sample. scioPhosho enables targeted, rapid, and cost-effective research.

 

Key Features

  • more than 1,400 highly relevant proteins are profiled in a single assay
  • Combines analysis of phosphorylation status with protein expression level analysis
  • Analysis of tyrosine, serine, and threonine phosphorylation
  • Analysis of individual phosphorylation types is available
  • 'Sample-to-result' service
  • Comprehensive data analysis and reporting
  • Customized study report
Protein abundance levels and phosphorylation status for one individual protein out of 900 proteins tested

Advantages

  • High-content screening of proteins and phosphorylation is time and resource efficient
  • Direct comparability by analyzing the level of protein expression and the level of phosphorylation in a single assay
  • Complete analysis from a minimal amount of sample
  • Coverage of important
    • Signaling pathways
    • Transcription factors
    • Receptor molecules
    • Kinases
  • Custom data analysis options available
    • Protein interaction network analysis
    • Biological and pathway classification 
    • Lists of differentially expressed proteins and levels of phosphorylation
  • Variety of sample formats possible without the potential bias of sample fractionation or sample depletion
  • Results presented in a publication-ready format

Applications

  • T-cell activation
  • Tissue treatment response
  • Cell cycle regulation
  • Oxidative stress response
  • Cell adhesion and motility
  • Phosphorylation profiling of various signaling pathways
    • FAK phosphorylation
    • PI3K-AKT pathway
    • p53 pathway regulation
    • Alzheimer pathway regulation

Which Sample Types can be Analyzed?

A wide range of samples can be analyzed with scioPhospho

  • Fresh-frozen tissue samples
  • Cellular samples
  • Cerebrospinal fluid (CSF)
  • Plasma or serum
  • Other sample types available upon request

A minimal amount of sample is required*, for example

  • Plasma sample: 5µl
  • Tissue: 1mg (fresh-frozen)
  • Cells: 100,000
  • CSF: 5µl

 

 Our Sample-to-Result Service

As part of our analysis service, we will not only perform the microarray experiments but will also support you with an appropriate microarray study design and sample selection to best address your scientific questions. After we receive your samples, you will receive a customized study report including statistical analysis within 3-4 weeks.

Our analysis service includes:

  • Definining a suitable study design
  • Sample preparation: Protein extraction, concentration measurements, quality control, and sample purification
  • Microarray analysis
  • Raw data acquisition and data normalisation
  • Data analysis including cluster analysis
  • Statistical testing for differentially abundant proteins
  • Statistical testing for differentially phosphorylated proteins
  • Comprehensive study report

 

Contact us 

 

Case Study

Eight treated cell line samples were compared with eight control samples. Multiple proteins were identified as differentially expressed (x-axis) and/or phosphorylated (y-axis). The left graph provides an overview of the expression/phosphorylation differences for all tested proteins in the two sample groups, while the right graphs show individual protein levels. The sample status is indicated as C for control or T for treated.

 

Reference Customers

Prof. Dr. Mathias Heikenwälder, German Cancer Research Center, Heidelberg, Germany

Dr. Caroline Pabst. University Hospital Halle, Germany

 

More Information

Download our scioPhospho or scioDiscover service brochure.

Information on protein and pathway content / coverage.

Get in touch to answer any remaining questions.

Ask for a quotation to get your study started.

 

*Minimum quantity. These values may vary depending on the sample type, study design, storage conditions. and additional parameters.

 

 

Our service portfolio

scioPhospho: protein profiling and phosphorylation status

scioPhospho: protein profiling and phosphorylation status

Our scioPhospho analysis combines protein expression profiling using scioDiscover with analysis of the corresponding protein's phosphorylation status. More than 1,400 proteins are analyzed in parallel, covering key pathways in diseases such as cancer, neurological disorders and organ failure.  This combination provides a comprehensive overview of signaling events and pathway activity…
Read more
scioUbi: protein profiling and ubiquitination status

scioUbi: protein profiling and ubiquitination status

Protein & ubiquitination profiling scioUbi is a high-content protein expression and ubiquitination level analysis. With scioUbi you can analyse more than 1,400 proteins in a single assay.   Features Screen…
scioDiscover - Protein Profiling on the Expression Level

scioDiscover - Protein Profiling on the Expression Level

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised…
scioCD - Cell Surface Marker and Cytokine Profiling

scioCD - Cell Surface Marker and Cytokine Profiling

Characterize Your Cell Type! Cell Composition Analysis in Tissue Samples CD-Marker Expression Profiles Increased Throughput at High Sensitivity Levels High Reproducibility       Our scioCD profiling service covers 349 different…
scioCyto : Cytokine Profiling

scioCyto : Cytokine Profiling

scioCyto : Cytokine profiling scioCyto is a high-content analysis service for multiplex cytokine and chemokine profiling on protein level. A great variety of samples such as plasma, tissue, cells or cell…

COVID-19 related activities and services

covid 19 portfolio web

News

New Article | Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia

| September 2023 | New Article: Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. Sciomics supported this study by scioCyto serum analysis in a mouse cancer model.

Taylor, J., Uhl, L., Moll, I. et al. Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia. Nat Cancer 4, 1544–1560 (2023)
New Article | Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes

| July 2023 | New Article: Fiedler et al. developed a novel methodology for vitamin B6 diagnostics. We supported the project by the production of custom antibody microarray targeting signature human PLP-DE and testing respective samples.

New Article | Microbiota Influences Chemotherapy in Pancreatic Cancer

| February 2023 | New Article: In the study Tintelnot et al. identified a microbiota-derived metabolite that has clinical implications in the treatment of pancreatic cancer. Sciomics supported the authors by a protein profiling study of tumours derived from a mouse model upon treatment with 3-IAA and Firinox.

Tintelnot et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615, 168-174 (2023)
New Article | Predicting a severe Covid-19 disease

| April 2023 | New Article: In a protein biomarker development project initiated by Sciomics, we have identified protein biomarker panels predicting development of a severe Covid.19  disease.

Hufnagel K., Fathi A. et al. Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease. Communications Medicine 3,51 (2023)
New Sciomics Proteomics Research Blog has Launched!

Sciomics Protomics Research Blog

 

At Sciomics, we are dedicated to advancing healthcare through proteomics research. We are collaborating with research groups and big pharma, alongside our in-house biomarker research initiatives. To make this research more accessible to you, we are launching the new Sciomics science blog!

The first study we will feature was published this year in a journal in the Nature publishing group. It's a topic that affects us all. Any guesses? Stay tuned!

 

 

Testimonials

Dr. Matthew Wright

Chief Scientific Officer, Kinarus Therapeutics AG, Basel, Switzerland

"We are a small biotech company without our own wet labs. Sciomics recommended a UK CRO that performed cell culture experiments for our studies. Sciomics seamlessly coordinated the transfer of the biologic materials to their facility and performed the scioCD panel to characterize cell surface markers and cytokines in cell lines treated with our small molecule drug candidates. The Sciomics data were instrumental in supporting our IP protection strategy. Their advice was very helpful and they worked with us to extract the most out of the data. We are very satisfied and highly recommend the Sciomics platform and the team."

Product: scioCD

Kyriaki Barmpa

PhD Candidate, Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg

"By collaborating with Sciomics, we conducted a detailed analysis of the proteome of striatum organoids, uncovering significant differences that further assisted our research. Their communication was highly efficient, and the results were delivered promptly."

Product: scioPhospho